Phreesia’s Danielle Lynch Named One of MM+M’s ‘Women to Watch’ for 2022
March 31 2022 - 4:15PM
Business Wire
Phreesia is pleased to announce that the healthcare marketing
industry trade MM+M has named Danielle Lynch, Vice President,
Client Experience, to its Women to Watch class of 2022.
Now in its seventh year, the program recognizes successful
leaders and up-and-coming talent in the industry who have inspired
their colleagues, showcased new ways of doing business and taken
healthcare marketing to new heights. Lynch was chosen as one of
just 25 women to receive this year’s honors.
“I’m honored to be recognized by MM+M alongside such esteemed
women leaders in the healthcare marketing field,” Lynch said. “I’m
incredibly proud of the Phreesia Life Sciences team and the success
we’ve achieved through hard work and collaboration.”
Since playing a pivotal role in taking Phreesia public in 2019,
Lynch has doubled the size of her team and helped increase Life
Sciences revenue by nearly 100%. She is admired by her colleagues
for her innovation, tenacity, and her continued contributions to
Phreesia's mission of creating a better, more engaging healthcare
experience.
“We are thrilled to see Danielle awarded this well-deserved
honor,” David Linetsky, Phreesia’s Senior Vice President, Life
Sciences, said. “Danielle built the Client Experience team—the
engine behind Phreesia Life Sciences’ significant growth—from the
ground up, and her vision and leadership have been instrumental to
the team’s success.”
About Phreesia Life Sciences
Phreesia empowers life sciences companies to connect
meaningfully with clinically relevant patients, delivering targeted
health content in a one-to-one setting. Our PatientConnect offering
identifies and motivates the right patients to initiate meaningful
brand conversations, and our PatientInsights product enables our
clients to better understand their target patient populations.
Phreesia meets patients where they are, both virtually and
in-person, and reaches them at multiple touchpoints throughout
their healthcare journey. To learn more about Phreesia Life
Sciences, visit lifesciences.phreesia.com.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220331005973/en/
Media Contact: Carly Helfand chelfand@phreesia.com
332-910-6768
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Sep 2024 to Oct 2024
Prudential Financial JR Sub Nts 12/31/2068 (NYSE:PHR.CL)
Historical Stock Chart
From Oct 2023 to Oct 2024